Century Therapeutics (IPSC) Invested Capital (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Invested Capital of $1.9 million for Q1 2026, down 48.39% quarter-over-quarter from $3.8 million in Q4 2025.
Century Therapeutics (IPSC) Invested Capital (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Invested Capital for 6 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $14.0 million (changed N/A YoY), while the FY2025 annual figure was $3.8 million, changed N/A from the prior year.
- Invested Capital declined to $1.9 million in Q1 2026 per IPSC's latest filing, from $3.8 million in the prior quarter.
- Across five years, Invested Capital topped out at $10.3 million in Q1 2023 and bottomed at $1.6 million in Q2 2022.
- Historically, Invested Capital has averaged $5.2 million across 4 years, with a median of $4.0 million in 2022.
- On a YoY basis, Invested Capital climbed as much as 525.79% in 2022 and fell as far as 84.06% in 2022.
- Century Therapeutics' Invested Capital stood at $6.5 million in 2022, then soared by 58.37% to $10.3 million in 2023, then plunged by 63.51% to $3.8 million in 2025, then slumped by 48.39% to $1.9 million in 2026.
- Business Quant data shows IPSC's Invested Capital at $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 8.34 Mn |
| Mar 31, 2023 | 10.30 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Sep 30, 2022 | 4.04 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 10.00 Mn |
| Dec 31, 2020 | 9.64 Mn |